Pathophysiological changes occurring in acute kidney injury and chronic kidney disease are associated with profound alterations in the pharmacokinetics and pharmacodynamics of many drugs. A recent paper reports the recommendations from a KDIGO conference on drug-dosing considerations in patients with acute and chronic forms of kidney disease. The group hope that their recommendations will stimulate research to improve outcomes of patients with kidney disease.